Home Ingredients Flexigo™ (Devil's Claw Joint Health)
Joint Health

Flexigo™ (Devil's Claw Joint Health)

Harpagophytum procumbens
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Flexigo™ is a STANDARDIZED DEVIL'S CLAW EXTRACT (Harpagophytum procumbens, also Harpagophytum zeyheri) from Southern Africa — developed by Nexira (France) as natural joint health solution. Distinguished by standardized harpagoside content up to 20% (HPLC method), 100% Devil's Claw (carrier-free), sustainable wild-harvest sourcing from Southern African partnerships, and EFSA pending claims for joint health. Used for joint comfort, mobility, and flexibility, particularly in active people and aging populations.

Studied Dose 1.8-3 g/day extract providing 50-100 mg harpagosides daily; varies by standardization
Active Compound Harpagosides (iridoid glycosides); typical standardization 1-30% harpagosides

Benefits

Joint Pain and Mobility (Clinical Evidence)

Multiple RCTs of Devil's Claw extracts (including Flexigo-grade) show pain reduction and improved mobility in osteoarthritis. systematic review confirmed efficacy. Effect comparable to non-pharmaceutical alternatives.

Supported by Trial 1

Inflammation Marker Reduction

Devil's Claw extracts modulate inflammatory pathways; reduce inflammation markers in some trials. Mechanism: harpagoside and other iridoid compounds inhibit COX-2, lipoxygenase, NF-κB pathway.

Supported by Trial 1, Trial 2

EFSA Pending Claims

Two pending EFSA claims for Harpagophytum procumbens: (1) 'Helps to maintain joint health'; (2) 'Helps to maintain flexible joints and good mobility'. Pending status; reflects substantial evidence base for joint applications.

Supported by Trial 1, Trial 2

Athletic Application

Useful for active people and athletes with joint stress — supports recovery and ongoing joint comfort with intense use. Adjunct to comprehensive joint care.

Supported by Trial 2, Trial 1

Carrier-Free 100% Active Ingredient

Flexigo™ is 100% Devil's Claw (no carrier); allows precise dosing and high active concentration. Distinguishes from products diluted with maltodextrin or other fillers.

Supported by Trial 1, Trial 2

Mechanism of action

1

Harpagoside Anti-Inflammatory Activity

Harpagoside (and harpagide, procumbide) are iridoid glycosides — primary actives. Inhibit COX-2, lipoxygenase pathway, NF-κB activation. Mechanism similar in direction to NSAIDs but weaker effect; better tolerability.

2

Cytokine Modulation

Reduces pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6); contributes to joint inflammation reduction.

3

Cartilage Protection (Theoretical)

Some animal evidence for chondroprotective effects — protection of cartilage from inflammatory degradation. Clinical translation incomplete.

4

Sustainable Wild-Harvest Sourcing

Devil's Claw grows wild in Southern Africa (Namibia, Botswana, South Africa); roots harvested sustainably with rotation systems. Nexira maintains long-term sustainable supply chain partnerships.

Clinical trials

1
Devil's Claw for Osteoarthritis — Chrubasik 2003 Systematic Review
PubMed

Systematic review of Devil's Claw RCTs for arthritis pain.

Pooled across multiple osteoarthritis trials.

Significant evidence for pain reduction and mobility improvement vs placebo. Effect comparable to other natural anti-inflammatory approaches. Established Devil's Claw as evidence-based joint health intervention.

2
Devil's Claw vs NSAIDs — Comparative Trials
PubMed

Studies comparing Devil's Claw extracts to NSAIDs for joint pain.

Osteoarthritis patients.

Devil's Claw less effective than NSAIDs but better tolerated; reasonable adjunct or alternative for those needing chronic joint support without NSAID GI/cardiovascular risks.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (nausea, diarrhea) — most common.
Headache.
Theoretical bleeding risk at high doses (modest antiplatelet effects).
Allergic reactions rare.
Bitter taste of extract.

Important Drug interactions

ANTICOAGULANTS — theoretical bleeding risk; modest at typical doses; consult.
DIABETES MEDICATIONS — modest hypoglycemic effects; monitor.
GASTRIC ULCERS / SEVERE GERD — Devil's Claw may stimulate gastric acid; AVOID with active ulcer disease.
ANTI-ARRHYTHMIC MEDICATIONS — theoretical effects on cardiac function.
PREGNANCY — uterotonic effects historically; AVOID supplementation in pregnancy.
Lactation — limited safety data; AVOID.
Featured In

Symptom-specific supplement guides

🦴Best Supplements for Joint Pain

More Joint Health Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Bone Health
Copper
Copper is an essential trace mineral and cofactor for over 30 enzymatic reactions, includi…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Anti-Inflammatory
Meriva® (Curcumin Phytosome — Indena)
Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's…

Explore Other Ingredients

Cognitive
Ashwagandha
Ashwagandha is an adaptogenic herb that may reduce stress, enhance mood, and support overa…
Cognitive
L-Theanine
L-Theanine, an amino acid primarily found in green tea (Camellia sinensis), is commonly su…
Cognitive
Suntheanine®
Suntheanine® is a patented, 100% pure L-isomer theanine produced via an enzymatic process…

Frequently asked questions about Flexigo™ (Devil's Claw Joint Health)

What is Flexigo™ (Devil's Claw Joint Health)?

Flexigo™ is a STANDARDIZED DEVIL'S CLAW EXTRACT (Harpagophytum procumbens, also Harpagophytum zeyheri) from Southern Africa — developed by Nexira (France) as natural joint health solution.

What does Flexigo™ (Devil's Claw Joint Health) do?

Harpagoside (and harpagide, procumbide) are iridoid glycosides — primary actives. Inhibit COX-2, lipoxygenase pathway, NF-κB activation. Mechanism similar in direction to NSAIDs but weaker effect; better tolerability. In clinical research, Flexigo™ (Devil's Claw Joint Health) has been studied for joint pain and mobility (clinical evidence), inflammation marker reduction, efsa pending claims.

Who should take Flexigo™ (Devil's Claw Joint Health)?

Flexigo™ (Devil's Claw Joint Health) may be most relevant for people interested in joint health. It has been clinically studied for joint pain and mobility (clinical evidence), inflammation marker reduction, efsa pending claims. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Flexigo™ (Devil's Claw Joint Health) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Flexigo™ (Devil's Claw Joint Health)?

For anti-inflammatory and joint goals, Flexigo™ (Devil's Claw Joint Health) is typically taken with meals — fat-containing food often improves absorption for fat-soluble compounds. Daily consistency matters more than precise timing for cumulative anti-inflammatory effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Flexigo™ (Devil's Claw Joint Health) worth taking?

Flexigo™ (Devil's Claw Joint Health) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Flexigo™ (Devil's Claw Joint Health) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Flexigo™ (Devil's Claw Joint Health)?

The clinically studied dose for Flexigo™ (Devil's Claw Joint Health) is 1.8-3 g/day extract providing 50-100 mg harpagosides daily; varies by standardization. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Flexigo™ (Devil's Claw Joint Health) used for?

Flexigo™ (Devil's Claw Joint Health) is studied for joint pain and mobility (clinical evidence), inflammation marker reduction, efsa pending claims. Multiple RCTs of Devil's Claw extracts (including Flexigo-grade) show pain reduction and improved mobility in osteoarthritis. systematic review confirmed efficacy. Effect comparable to non-pharmaceutical alternatives.